United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Apr 1, 2026 · Filed Apr 2, 2026

On Apr 1, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$581.63 for US$5.53M under a trading plan, leaving 40,513 shares. Filed Apr 2, 2026 (Form 4).

Sold
9,500 shares
Price
US$581.63 average (US$570.87 to US$596.11)
Value
US$5.53M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 1, 2026Common StockOption exercise9,500US$146.0350,013Direct
Apr 1, 2026Common StockSale538US$570.8749,475Direct
Apr 1, 2026Common StockSale801US$571.5848,674Direct
Apr 1, 2026Common StockSale931US$572.8147,743Direct
Apr 1, 2026Common StockSale310US$573.9247,433Direct
Apr 1, 2026Common StockSale481US$574.8746,952Direct
Apr 1, 2026Common StockSale399US$576.0246,553Direct
Apr 1, 2026Common StockSale360US$577.1346,193Direct
Apr 1, 2026Common StockSale240US$578.5645,953Direct
Apr 1, 2026Common StockSale280US$579.3545,673Direct
Apr 1, 2026Common StockSale190US$580.5445,483Direct
Apr 1, 2026Common StockSale610US$581.7244,873Direct
Apr 1, 2026Common StockSale602US$582.7544,271Direct
Apr 1, 2026Common StockSale31US$583.5644,240Direct
Apr 1, 2026Common StockSale160US$585.1144,080Direct
Apr 1, 2026Common StockSale247US$586.6143,833Direct
Apr 1, 2026Common StockSale846US$587.6042,987Direct
Apr 1, 2026Common StockSale450US$588.6342,537Direct
Apr 1, 2026Common StockSale469US$589.6642,068Direct
Apr 1, 2026Common StockSale155US$590.6941,913Direct
Apr 1, 2026Common StockSale280US$591.6441,633Direct
Apr 1, 2026Common StockSale240US$592.9841,393Direct
Apr 1, 2026Common StockSale440US$594.1140,953Direct
Apr 1, 2026Common StockSale200US$595.2940,753Direct
Apr 1, 2026Common StockSale240US$596.1140,513Direct

Source

View original at SEC

Related